Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Wave Life Sciences stock

Own Wave Life Sciences stock in just a few minutes.

Fact checked

Wave Life Sciences Ltd is a biotechnology business based in the US. Wave Life Sciences shares (WVE) are listed on the NASDAQ and all prices are listed in US Dollars. Wave Life Sciences employs 301 staff and has a trailing 12-month revenue of around USD$13 million.

How to buy shares in Wave Life Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Wave Life Sciences. Find the stock by name or ticker symbol: WVE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Wave Life Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Wave Life Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Wave Life Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Wave Life Sciences share price

Use our graph to track the performance of WVE stocks over time.

Wave Life Sciences shares at a glance

Information last updated 2021-02-23.
52-week rangeUSD$6.61 - USD$19.98
50-day moving average USD$10.0268
200-day moving average USD$9.7843
Wall St. target priceUSD$16.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-5.145

Buy Wave Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Wave Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Wave Life Sciences financials

Revenue TTM USD$13 million
Gross profit TTM USD$-159,448,000
Return on assets TTM -34.27%
Return on equity TTM -149.01%
Profit margin 0%
Book value $2.219
Market capitalisation USD$474.1 million

TTM: trailing 12 months

Shorting Wave Life Sciences shares

There are currently 4.3 million Wave Life Sciences shares held short by investors – that's known as Wave Life Sciences's "short interest". This figure is 2.5% down from 4.4 million last month.

There are a few different ways that this level of interest in shorting Wave Life Sciences shares can be evaluated.

Wave Life Sciences's "short interest ratio" (SIR)

Wave Life Sciences's "short interest ratio" (SIR) is the quantity of Wave Life Sciences shares currently shorted divided by the average quantity of Wave Life Sciences shares traded daily (recently around 681703.18471338). Wave Life Sciences's SIR currently stands at 6.28. In other words for every 100,000 Wave Life Sciences shares traded daily on the market, roughly 6280 shares are currently held short.

However Wave Life Sciences's short interest can also be evaluated against the total number of Wave Life Sciences shares, or, against the total number of tradable Wave Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Wave Life Sciences's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Wave Life Sciences shares in existence, roughly 90 shares are currently held short) or 0.1106% of the tradable shares (for every 100,000 tradable Wave Life Sciences shares, roughly 111 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Wave Life Sciences.

Find out more about how you can short Wave Life Sciences stock.

Wave Life Sciences share dividends

We're not expecting Wave Life Sciences to pay a dividend over the next 12 months.

Wave Life Sciences share price volatility

Over the last 12 months, Wave Life Sciences's shares have ranged in value from as little as $6.61 up to $19.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Wave Life Sciences's is 0.3863. This would suggest that Wave Life Sciences's shares are less volatile than average (for this exchange).

Wave Life Sciences overview

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site